Indicators of fibrinolysis during cardiopulmonary bypass after exogenous antithrombin-III administration for acquired antithrombin III deficiency

被引：15
作者：
VanNorman, GA
Gernsheimer, T
Chandler, WL
Cochran, RP
Spiess, BD
机构：
[1] UNIV WASHINGTON,DEPT CARDIAC SURG,SEATTLE,WA 98195
[2] UNIV WASHINGTON,DEPT HEMATOL,SEATTLE,WA 98195
[3] UNIV WASHINGTON,DEPT LAB MED,SEATTLE,WA 98195
来源：
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA | 1997年 / 11卷 / 06期
关键词：
fibrinolysis; coagulation; cardiopulmonary bypass; anti-thrombin-III;
D O I：
10.1016/S1053-0770(97)90172-5
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
[No abstract available]
引用
收藏
页码：760 / 763
页数：4
相关论文
共 25 条
[1]  
BOISCLAIR MD, 1993, BLOOD, V82, P3350
[2]  
CHANDLER WL, 1995, THROMB HAEMOSTASIS, V74, P1293
[3]   BLOOD-TRANSFUSION COSTS - A MULTICENTER STUDY [J].
FORBES, JM ;
ANDERSON, MD ;
ANDERSON, GF ;
BLEECKER, GC ;
ROSSI, EC ;
MOSS, GS .
TRANSFUSION, 1991, 31 (04) :318-323
[4]   DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ANTITHROMBIN-III CONCENTRATES IN SEPTIC SHOCK WITH DISSEMINATED INTRAVASCULAR COAGULATION [J].
FOURRIER, F ;
CHOPIN, C ;
HUART, JJ ;
RUNGE, I ;
CARON, C ;
GOUDEMAND, J .
CHEST, 1993, 104 (03) :882-888
[5]  
GRODMANGROSS CA, 1987, DRUG INTEL CLIN PHAR, V21, P180
[6]  
HAMSTEN A, 1987, LANCET, V2, P3
[7]  
HASHIMOTO K, 1995, ANN THORAC SURG, V58, P799
[8]  
KHURI SF, 1992, J THORAC CARDIOV SUR, V104, P94
[9]   INFLUENCE OF FIBRINOGEN DEGRADATION PRODUCTS ( FDP ) ON PLATELET AGGREGATION ADHESIVENESS + VISCOUS METAMORPHOSIS [J].
KOWALSKI, E ;
KOPEC, M ;
WEGRZYNOWICZ, Z .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1964, 10 (3-4) :406-+
[10]   INCREASED FIBRINOLYTIC-ACTIVITY IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS OPERATION [J].
KUCUK, O ;
KWAAN, HC ;
FREDERICKSON, J ;
WADE, L ;
GREEN, D .
AMERICAN JOURNAL OF HEMATOLOGY, 1986, 23 (03) :223-229
123